Cannabis and cannabis-derived products are subject to the same laws and regulations as other FDA-regulated products. This means that these products must be properly labeled, and manufacturers must ensure that they do not make false or misleading claims about their products. In addition, all cannabis-derived products must undergo FDA premarket review before they can be marketed in the United States. To date, the FDA has approved four cannabis drug products, mainly focused on CBD and THC. They are:
- Marinol
- Syndros
- Cesamet
- Epidiolex
There are a few specific products that the FDA has acknowledged to be “generally recognized as safe” or GRAS for use in human food. These are hemp seed oil, hemp protein powder, and hulled hemp seed. The FDA will continue to update the public as it learns more about CBD. The FDA is also working with federal partners on issues related to cannabis and cannabis-derived products, including CBD. FDA will continue to consider whether there are additional measures we should take to address the public health concerns raised by the use of these products.
Food and Drug Administration Authority
FDA studies which CBD products fit within the current legal framework and which pose excessive health and safety risks. The FDA is also responsible for advancing public health by helping to speed innovations that make medical products more effective, safer, and more affordable and by helping the public get the accurate, science-based information they need to use medical products and services safely. The FDA has seen only limited data about CBD safety and these data point to real risks that need to be considered before taking CBD for any reason.
The Food and Drug Administration (FDA) performs its work through a network of offices located across the country, including its headquarters in Silver Spring, Maryland. The FDA also has 13 laboratories located across the United States that provide analytical and research support to the FDA’s field offices. The Food and Drug Administration’s (FDA) job is to protect public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, medical devices, our nation’s food supply, cosmetics, and products that emit radiation.
Cannabis and Cannabidiol (CBD)
Cannabis and Cannabidiol (CBD) are two of the most popular substances in the world. They are both derived from the cannabis plant and have many similarities. However, there are also some key differences between the two.
Cannabis is a psychoactive substance that has been used for centuries for its medicinal and recreational properties. CBD, on the other hand, is a non-psychoactive compound that is thought to have a wide range of therapeutic benefits. While both Cannabis and Cannabidiol (CBD) are derived from the cannabis plant, they are different in terms of their effects on the body. Cannabis produces a psychoactive effect, while CBD does not.
CBD is thought to have a wide range of therapeutic benefits, including reducing anxiety, pain, and inflammation. It is also being studied for its potential to treat a variety of other conditions.
If you are considering using either Cannabis or Cannabidiol (CBD), it is important to be aware of the potential risks and benefits of each substance. Speak to your doctor or a qualified healthcare professional to get more information.
What Can Cannabis Do?
Cannabis has been used for medicinal purposes for centuries. Modern science is beginning to understand how cannabis can be used to treat various medical conditions. Cannabis has been shown to be effective in treating a variety of medical conditions, including:
- Chronic pain
- Inflammation
- Nausea and vomiting
- Anxiety
- Depression
- Insomnia
- Cancer
- Epilepsy and seizure disorders
Cannabis is a safe and effective alternative to many traditional medications. Talk to your doctor about whether cannabis could be right for you.
